Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems.
Health care services provider Encompass Health (NYSEEHC)
will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Health coverage company Centene (NYSECNC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 3.4% year on year to $40.81 billion. Its non-GAAP profit of $0.80 per share was 62.2% above analysts’ consensus estimates.
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Centene raised its 2025 premium revenue outlook to $158 billion-$160 billion. Q4 results beat estimates with $40.8 billion in sales and an adjusted EPS of $0.80.
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's disappointing fourth-quarter 2024 revenue results.
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 9-13, 2024.
